These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2427844)

  • 41. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
    Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of carvedilol and atenolol for angina pectoris.
    Freedman SB; Jamal SM; Harris PJ; Kelly DT
    Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.
    Silke B; Verma SP; Guy S
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):681-7. PubMed ID: 1679661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of bevantolol and atenolol in chronic stable angina.
    Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
    Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized double-blind study of pindolol in patients with stable angina pectoris.
    Harston WE; Friesinger GC
    Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of celiprolol in hypertension and angina pectoris. Introduction.
    Norris RJ
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1195-6. PubMed ID: 1672600
    [No Abstract]   [Full Text] [Related]  

  • 48. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
    Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
    J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
    van der Does R; Eberhardt R; Derr I; Ehmer B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol.
    Ray SG; McCann G; Henderson E; MacFarlane N; Christie J; Norrie J; Ford I; Grant S; Dargie HJ
    Eur Heart J; 1994 Nov; 15(11):1566-70. PubMed ID: 7835373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
    de Muinck ED; Buchner-Moell D; van de Ven LL; Lie KI
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):870-5. PubMed ID: 1376806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.
    Silke B; Rosenthal F; Taylor S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S122-6. PubMed ID: 2427841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B; Dahlqvist A; Raak A; Wrege U
    Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
    Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
    J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
    Riddell JG; Shanks RG; Brogden RN
    Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of orally administered celiprolol in patients with chronic atrial fibrillation.
    Lin SK; Morganroth J; Heng M; Rubler S; Baird W; Atwood JE; Mostow N; Scarse OM; Yu P; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S112-5. PubMed ID: 2427838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
    Winsor T; Berger HJ
    Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety profile of celiprolol.
    Lamon KD
    Am Heart J; 1988 Nov; 116(5 Pt 2):1438-40. PubMed ID: 2903657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.